Global Molecular Point-of-Care Testing Market Growth (Status and Outlook) 2025-2031
The global Molecular Point-of-Care Testing market size is predicted to grow from US$ 7918 million in 2025 to US$ 10540 million in 2031; it is expected to grow at a CAGR of 4.9% from 2025 to 2031.
Molecular point-of-care (POC) testing is a type of diagnostic testing that uses nucleic acid amplification techniques such as polymerase chain reaction (PCR) to rapidly detect the presence of specific genetic material, such as DNA or RNA, directly in patient samples.
The global molecular point-of-care testing (POCT) market refers to the market for diagnostic tests that can be performed at or near the point of patient care, providing rapid and accurate results for a wide range of diseases and conditions.
Key features:- Increasing demand for rapid and accurate diagnostic testing
- Technological advancements in molecular diagnostics
- Rising prevalence of infectious diseases
- Growing focus on personalized medicine
- COVID-19 pandemic impact
- Polymerase Chain Reaction (PCR)
- Loop-mediated Isothermal Amplification (LAMP)
- Nucleic Acid Sequence-based Amplification (NASBA)
- Infectious Diseases
- Genetic Disorders
- Pregnancy Testing
- Diagnosis of Cancer
- Pharmacogenomics
- Americas
- APAC
- Europe
- Middle East & Africa
- Roche Molecular Diagnostics
- Roche Diagnostics
- Abbott Laboratories
- Danaher Corporation
- bioMérieux, Inc.
- Hologic, Inc.
- Meridian Bioscience, Inc.
- Saw Diagnostics
- Siemens Healthineer
- Sona Nanotech
- T2 Biosystems
- Talis Biomedical
- Thermo Fisher Scientific Inc.
- Veramarx
- XCR Diagnostics
- Zhejiang Orient Gene Biotech
- What are the major trends shaping the market?
- What factors are driving the growth of the market?
- What are the challenges faced by the industry?
Frequently Asked Questions
Molecular Point-of-Care Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Molecular Point-of-Care Testing report is categorised based on following features:
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market
Molecular Point-of-Care Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.